Common use of Inspection Findings and Responses Clause in Contracts

Inspection Findings and Responses. Principal Investigator and Institution will promptly forward to CRO and Pfizer copies of any inspection findings that either receives from a regulatory authority in relation to the Study. Whenever feasible and permitted by law, Principal Investigator and Institution will also provide CRO and Pfizer with an opportunity to prospectively review and comment on any responses to regulatory authority inspections in regard to the Study. e.

Inspection Findings and Responses. Principal Investigator and Institution will promptly forward to CRO and Pfizer copies of any inspection findings that either receives from a regulatory authority in relation to the Study. Whenever feasible and permitted by law, Principal Investigator and Institution will also provide CRO and Pfizer with an opportunity to prospectively review and comment on any responses to regulatory authority inspections in regard to the Study. e..

Inspection Findings and Responses. Principal Investigator and Institution Institute will promptly forward to CRO and Pfizer copies of any inspection findings that either receives from a regulatory authority in relation to the Study. Whenever feasible and permitted by law, Principal Investigator and Institution Institute will also provide CRO and Pfizer with an opportunity to prospectively review and comment on any responses to regulatory authority inspections in regard to the Study. e.13.

Inspection Findings and Responses. Principal Investigator and Institution will promptly forward to CRO and Pfizer Pfizer, or confirm that Principal Investigator has done so, copies of any inspection findings that either Institution receives from a regulatory authority in relation to the Study. Institution will also cooperate with Pfizer as needed to help ensure that Principal Investigator forwards any inspection findings that Principal Investigator alone receives in relation to the Study. Whenever feasible and permitted by law, Principal Investigator and Institution will also provide CRO and Pfizer with an opportunity to prospectively review and comment on any responses to regulatory authority inspections in regard to the Study. e.to

Inspection Findings and Responses. Principal Investigator and Institution will promptly forward to CRO and Pfizer Pfizer, or confirm that Principal Investigator has done so, copies of any inspection findings that either Institution receives from a regulatory authority in relation to the Study. Whenever feasible and permitted by law, Principal Investigator and Institution will also provide CRO and cooperate with Pfizer with an opportunity as needed to prospectively review and comment on any responses to regulatory authority inspections in regard to the Study. e.help ensure